Saturday March 2, 2019

14.00 What we learned from basic science studies on IPF?
Martin Kolb (Hamilton, ON - Canada)

14.20 Cryobiopsy: lesson learned and future perspectives
Alberto Cavazza (Reggio Emilia, Italy)

14.40 The role of imaging in fibrotic lung disease
Maurizio Zompatori (Milan, Italy)

15.00 Comorbidities on IPF: an underestimate issue
Antonella Caminati (Milan, Italy)

15.20 Discussion
 

15.50 Genetic and epigenetic factors in IPF
Bruno Crestani (Paris, France)

16.10 Hypersensitivity pneumonitis
Toby M. Maher (London, United Kingdom)

16.30 Antifibrotic therapy: only for IPF patients?
Ganesh Raghu (Seattle, WA - USA)

16.50 The therapy of IPF: what’s next?
Michael Kreuter (Heidelberg, Germany)

17.10 Discussion

17.30 Closing remarks